16 June 2020 Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre™ venous self-expanding stent system in subjects with…
19 June 2020 Aenorasis S.A. appointed exclusive distributor in Greece and Cyprus Aenorasis has net annual turnover of €34.9 million and was awarded the Boussias Communications Golden Distinction Healthcare Business Award in Greece (2019) Bladder cancer is globally…
17 June 2020 Monash University has signed a multi-year research collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance the understanding of the immune mechanisms underpinning Coeliac Disease and inform…
22 June 2020 Three new members of Cabinet have today been sworn in, with Natalie Hutchins, Shaun Leane and Danny Pearson joining the Andrews Labor Government Ministry. Formerly Minister for the Prevention of Family Violence, Natalie Hutchins will again be…
18 June 2020 To better understand the burden of the COVID-19 lockdown on the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia, MTPConnect recently undertook research, in partnership with L.E.K. Consulting, to explore the impacts of the…
17 June 2020 Melbourne – BioCurate, an independently-operated joint venture between the University of Melbourne and Monash University, has entered into an agreement with leading Australian commercialisation fund Uniseed to collaborate on projects of specific interest and facilitate…
2 June 2020 • Triolab AB appointed exclusive distributor in Sweden for Sienna’s hTERT test as well as future products in the portfolio • Triolab AB is a subsidiary of AddLife AB (ALIF-B: STO) a Swedish-based healthcare company…
12 June 2020 A trial led by the Murdoch Children’s Research Institute (MCRI) is recruiting 80 children and adolescents allergic to egg to test a pioneering new approach to food allergies. MCRI Professor Mimi Tang is developing a probiotic and peanut immunotherapy…
9 June 2020 CSL Limited announced that it has agreed to exercise its right to acquire Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development of a treatment for rejection in solid organ kidney transplant…
11 June 2020 Sydney, Australia – Azure Health Technology Limited (AZT) today announced that it has successfully completed the acquisition of all shares in Invictus BioPharma Ltd (IVB). AZT and the shareholders of IVB executed a Share Sale…
10 June 2020 Three extraordinary women were recognised today for their significant and inspirational leadership across Victoria’s health sector. Today’s BioMelbourne Network Women in Leadership Awards ceremony celebrated the three exceptional leaders, who were selected for their valuable…
10 June 2020 Highlights Human Research Ethics Committee approves Phase I human clinical trial of AD-214 No further regulatory review required First healthy volunteer subject expected to receive AD-214 in late July Top-line safety results from healthy volunteer…